Xuan Dung Ho

Xuan Dung Ho

Auto-generated profile, based on publicly available information

Xuan Dung Ho

Department of Oncology, University of Medicine and Pharmacy, Hue University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2017 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
XHXuan Dung Ho
Xuan Dung Ho
PPPhuong Phung
Phuong Phung
VLVan Q Le
Van Q Le
VNVan H Nguyen
Van H Nguyen
EREne Reimann
Ene Reimann
Sulev KoksSulev Koks
Sulev Koks
We performed whole transcriptome analysis of osteosarcoma bone samples. Initially, we sequenced total RNA from 36 fresh-frozen samples (18 tumoral bone samples and 18 non-tumoral paired samples) matching in pairs for each osteosarcoma patient. We also performed independent gene expression analysis of formalin-fixed paraffin-embedded samples to verify the RNAseq results. Formalin-fixed paraffin-embedded samples allowed us to analyze the effect of chemotherapy. Data were analyzed with DESeq2, edgeR and Reactome packages of R. We found 5365 genes expressed differentially between the normal bone and osteosarcoma tissues with an FDR below 0.05, of which 3399 genes were upregulated and 1966 were downregulated. Among those genes, BTNL9, MMP14, ABCA10, ACACB, COL11A1, and PKM2 were expressed differentially with the highest significance between tumor and normal bone. Functional annotation with the reactome identified significant changes in the pathways related to the extracellular matrix degradation and collagen biosynthesis. It was suggested that chemotherapy may induce the modification of ECM with important collagen biosynthesis. Taken together, our results indicate that changes in the degradation of extracellular matrix seem to be an important mechanism of osteosarcoma and efficient chemotherapy induces the genes related to bone formation. Impact statement: Osteosarcoma is a rare disease but it is of interest to many scientists all over the world because the current standard treatment still has poor results. We sequenced total RNA from 36 fresh-frozen paired samples (18 tumoral bone samples and 18 non-tumoral paired samples) from osteosarcoma patients. We found that differences in the gene expressions between the normal and affected bones reflected the changes in the regulation of the degradation of collagen and extracellular matrix. We believe that these findings contribute to the understanding of OS and suggest ideas for further studies.

11 December 2014 in Human Genomics
Verified
Journal Article
Open access
PDF file
EREne Reimann
Ene Reimann
Sulev KoksSulev Koks
Sulev Koks
XHXuan Dung Ho
Xuan Dung Ho
KMKatre Maasalu
Katre Maasalu
AMAare Märtson
Aare Märtson
Osteosarcoma (OS) is a prevalent primary malignant bone tumour with unknown etiology. These highly metastasizing tumours are among the most frequent causes of cancer-related deaths. Thus, there is an urgent need for different markers, and with our study, we were aiming towards finding novel biomarkers for OS. For that, we analysed the whole exome of the tumorous and non-tumour bone tissue from the same patient with OS applying next-generation sequencing. For data analysis, we used several softwares and combined the exome data with RNA-seq data from our previous study. In the tumour exome, we found wide genomic rearrangements, which should qualify as chromotripsis—we detected almost 3,000 somatic single nucleotide variants (SNVs) and small indels and more than 2,000 copy number variants (CNVs) in different chromosomes. Furthermore, the somatic changes seem to be associated to bone tumours, whereas germline mutations to cancer in general. We confirmed the previous findings that the most significant pathway involved in OS pathogenesis is probably the WNT/β-catenin signalling pathway. Also, the IGF1/IGF2 and IGF1R homodimer signalling and TP53 (including downstream tumour suppressor gene EI24) pathways may have a role. Additionally, the mucin family genes, especially MUC4 and cell cycle controlling gene CDC27 may be considered as potential biomarkers for OS. The genes, in which the mutations were detected, may be considered as targets for finding biomarkers for OS. As the study is based on a single case and only DNA and RNA analysis, further confirmative studies are required.

26 July 2021 in Genes
Verified
Journal Article
Open access
PDF file
EREmel Rothzerg
Emel Rothzerg
XHXuan Dung Ho
Xuan Dung Ho
Jiake XuJiake Xu
Jiake Xu
DWDavid Wood
David Wood
AMAare Märtson
Aare Märtson
Sulev KoksSulev Koks
Sulev Koks
The human genome encodes thousands of natural antisense long noncoding RNAs (lncRNAs); they play the essential role in regulation of gene expression at multiple levels, including replication, transcription and translation. Dysregulation of antisense lncRNAs plays indispensable roles in numerous biological progress, such as tumour progression, metastasis and resistance to therapeutic agents. To date, there have been several studies analysing antisense lncRNAs expression profiles in cancer, but not enough to highlight the complexity of the disease. In this study, we investigated the expression patterns of antisense lncRNAs from osteosarcoma and healthy bone samples (24 tumour-16 bone samples) using RNA sequencing. We identified 15 antisense lncRNAs (RUSC1-AS1, TBX2-AS1, PTOV1-AS1, UBE2D3-AS1, ERCC8-AS1, ZMIZ1-AS1, RNF144A-AS1, RDH10-AS1, TRG-AS1, GSN-AS1, HMGA2-AS1, ZNF528-AS1, OTUD6B-AS1, COX10-AS1 and SLC16A1-AS1) that were upregulated in tumour samples compared to bone sample controls. Further, we performed real-time polymerase chain reaction (RT-qPCR) to validate the expressions of the antisense lncRNAs in 8 different osteosarcoma cell lines (SaOS-2, G-292, HOS, U2-OS, 143B, SJSA-1, MG-63, and MNNG/HOS) compared to hFOB (human osteoblast cell line). These differentially expressed IncRNAs can be considered biomarkers and potential therapeutic targets for osteosarcoma.

2 April 2020 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
GKGea Kõks
Gea Kõks
EPEle Prans
Ele Prans
XHXuan D Ho
Xuan D Ho
BDBinh H Duy
Binh H Duy
HTHa Dt Tran
Ha Dt Tran
Sulev KoksSulev Koks
Sulev Koks
Nicotine dependence is an addiction to tobacco products and a global public health concern that in part would be influenced by our genetics. Smokers are reported to have reduced MAOA activity, but the results from genetic associations with this gene have been inconclusive. Two functionally relevant variable number tandem repeat (VNTR) domains, termed uVNTR and dVNTR, in the MAOA gene are well characterized transcriptional regulatory elements. In the present study, we analyzed uVNTR and dVNTR polymorphisms in the MAOA gene in the Vietnamese male population of smokers and non-smokers in order to assess the association of MAOA with the nicotine dependence measured by the Fagerström Test for Nicotine Dependence (FTND). Individual analysis of VNTRs separately identified uVNTR to be associated with the F6 question of the FTND indicating the stronger addiction to nicotine. No associations were found between the dVNTR and smoking behavior. The combination of dVNTR and uVNTR, that predicts low expression of MAOA (10–3 haplotypes), was significantly associated with the higher nicotine dependence (FTND score), longer smoking duration, and more persistent smoking behavior (fewer quit attempts). In conclusion, our study confirms that low MAOA expression is genetically predictive to the higher nicotine dependence. Impact statement: The present study combined the analysis of two transcriptional regulators, uVNTR and dVNTR, in the MAOA gene that is an enzyme responsible for the monoamine degradation and identified genetic interaction between these VNTRs in association with the nicotine dependence. The main impact is that when analyzing different populations in the genetic studies, the functionally meaningful variants should be combined rather than addressing individual elements separately (a mini polygenic risk score for a particular gene/locus). This combination is very rarely analyzed and therefore the study sets an example. Another impact is that we analyzed the genetic variability in the Asian population and therefore our data present a piece of information from underrepresented populations.

14 June 2022 in The Surgery Journal
Verified
Journal Article
Open access
PDF file
HHHuu Hoang
Huu Hoang
EEEtienne El-Helou
Etienne El-Helou
CPC Florin Pop
C Florin Pop
ASAmmar Shall
Ammar Shall
MZManar Zaiter
Manar Zaiter
VNVan C. Nguyen
Van C. Nguyen
Primary breast tuberculosis (TB) is a rare extrapulmonary TB mainly affecting young women of childbearing age from endemic countries. Its incidence is increasing in immunocompromised and HIV-infected people and with the emergence of drug-resistant strains of Mycobacterium tuberculosis (MTB). There are no specific clinical signs suggestive of this disease, it often presents as a hard mass or breast abscess. There is an overlap of features with other inflammatory, infectious, benign lesions, fat necrosis and malignant neoplasms of the breast. The detection of MTB remains the gold standard for diagnosis. Several other diagnostic modalities are used, with varying lack of sensitivity and specificity, and with a range of false negatives. A quarter of cases were treated solely on the basis of clinical, imaging or histological suspicion, without confirmation of the diagnosis. Therefore, we report the case of a young Vietnamese woman, presented for a nonhealing breast abscess, and diagnosed with breast TB based on the patient's ethnicity, histological findings, lack of clinical response to conventional antibiotic therapy, and a good clinical response to anti-TB treatment.

20 May 2016 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
XHXuan Dung Ho
Xuan Dung Ho
PPPhuong Phung
Phuong Phung
VLVan Quang LE
Van Quang LE
VNVan Hieu Nguyen
Van Hieu Nguyen
EREne Reimann
Ene Reimann
Sulev KoksSulev Koks
Sulev Koks
E22508 Background: In present study we performed whole transcriptome analysis of bone samples of 18 osteosarcoma patients confirmed with histology and we compared the result of tumoral to non-tumoral samples from the same patient. We sequenced total RNA from 36 samples (18 tumoral bone samples and 18 non-tumoral bone samples) matching in pairs for each osteosarcoma patient. Methods: We extracted RNA from 18 tumor normal paired osteosarcoma fresh bone samples. RNAseq data were analyzed with DESeq2 and Reactome packages of R. Results: We found 6775 genes expressed differentially between the normal bone and osteosarcoma tissues. The differential expression had FDR corrected statistical significance below 0.1. 4092 genes were up-regulated and 2683 were down-regulated. Among those genes, BTNL9, MMP14, ABCA10, ACACB, COL11A1 and PKM2 were expressed differentially with the highest significance between tumor and normal bone. Functional annotation with the Reactome identified significant changes in the pathways related to the extracellular matrix degradation and collagen biosynthesis. Activation of PKM2 indicates the Warburg effect in tumor tissues. Conclusions: We identified differential expression of 6775 genes between the normal and osteosarcoma tissues with very high confidence. The up-regulation of COL family genes (COL11A1, COL2A1, COL10A1, COL3A1, COL6A1) with interaction with some others indicates the changes in the regulation of the synthesis and degradation of collagen and extracellular matrix that seems to be an important mechanism of osteosarcoma.